About 6.5 million men in the UK have experienced male pattern baldness – the most common type of hair loss.
Some might notice signs of thinning sooner than others, but it’s estimated that most men will have noticed some hair loss by 60.
Meanwhile, up to half of women aged 70 and above deal with female pattern baldness.
Currently, the usual treatments for those seeking to regrow lost hair are minoxidil (suitable for men and women who are neither pregnant nor breastfeeding) and finasteride (for men only).
But these only work for some people, and only offer benefits as long as they’re used.
Plus, they’re unavailable on the NHS (making long-running usage pretty costly) and take a long time to deliver results. They can come with side effects too, like palpitations.
But a new paper published in Nature Communications offers an exciting prospect.
Researchers think they might have made a comb that “significantly increases hair restoration efficacy in an androgenetic alopecia mouse model, improving outcome from ~70% to nearly 100% within one month compared to conventional topical minoxidil treatment”.
Patient Perfect via Unsplash
The comb is electric
The comb the scientists used in this study – the “Detangler”, described as a “comb-shaped bioelectronic system” – was tested on mice.
It “features electronic teeth embedded with height-differentiated electrodes and integrated drug-loading modules, which generate an enhanced electric field penetrating up to ~9 times deeper into hair follicle regions than conventional external application,” the paper reads.
In other words, it pulses electric fields from comb teeth of different lengths. The scientists said this variation makes the electric field more powerful – if the teeth were all the same length, the study authors wrote, this would be 2.63 times weaker.
The comb could offer two benefits. Firstly, the electricity itself can stimulate hair follicles, potentially helping them to grow (electrostimulation).
Secondly, the shorter teeth of the comb administer treatments deeper into the surface of the scalp. A process called electroporation makes cell membranes more permeable, so medications can reach further.
Genetic treatments included a VEGF-A plasmid, which encourages the growth of blood vessels around hair follicles, and SRD5A2 siRNA, which suppresses a follicle-shrinking hormone.
The result has so far only been seen in mice
Researchers have only tested this treatment in mice so far – but the results have been promising.
They shaved hair from the backs of mice and watched to see how quickly it regrew with different treatment approaches. Those left untreated regrew 1% of their hair in 28 days.
Mice only treated with the comb’s electrostimulation regrew 40% of their lost hair, meanwhile. But finasteride and minoxidil seemed more effective than the comb alone, leading to 50% and 70% hair growth, respectively.
However, the best result of all came with a combination of the tools and treatments the comb had to offer. Electrostimulation alongside VEGFA plasmid and SRD5A2 siRNA treatments led to a 97.85% regrowth – that’s “nearly 100%”.
We don’t know yet whether this will have the same effect on humans; more research is needed. Still, the study authors concluded that “the Detangle system proves safe and effective for deep tissue delivery in dermatology”.